Anti-ILT7-Antikörper

European patent · EP2913343 · In force

Register entry

Publication number
EP2913343
Application number
EP14186905
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Dec 20, 2006
Published
Sep 2, 2015
Granted
Aug 8, 2018
Protection ends at the latest
Dec 19, 2026
Next annual fee due
Dec 31, 2026
IPC classes
C07K 16/28 (2006.01)
A61K 39/395 (2006.01)
G01N 33/569 (2006.01)
C12N 5/00 (2006.01)
G01N 33/577 (2006.01)
G01N 33/566 (2006.01)
G01N 33/68 (2006.01)
A61P 37/00 (2006.01)
A61K 39/00 (2006.01)
Priority
JP 2005366465 20.12.2005
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jan 1, 2026

    Change

    Published in Swissreg on 01.01.2026

  2. Jan 1, 2025

    Change

    Published in Swissreg on 01.01.2025

  3. Jan 1, 2024

    Change

    Published in Swissreg on 01.01.2024

  4. Jan 1, 2023

    Change

    Published in Swissreg on 01.01.2023

  5. Aug 8, 2018

    Granted

    Published in Swissreg on 08.08.2018

Parties

Holder

SBI Biotech Co., Ltd.

1-6-1, Roppongi, Minato-ku Tokyo 106-6018, JP

Inventor

Arai, Naoko

Tokyo 108-0071, JP

Cho, Minkwon

Tokyo 108-0071, JP

Kamogawa, Yumiko

Tokyo 108-0071, JP

Ishida, Koji

Tokyo 108-0071, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.